公司回答表示：尊敬的投资者您好！公司十分关注二级市场股价，股价波动受多重因素影响。公司重整 引入的第一批财务投资人均不是持股5%以上的股东，不涉及应披露股份变动的情况，公司重整引入的 三家产业投资人均未发生减持。公司会持续关注大股东动态，若有触及需披露的信息将督促相关义务人 履行披露义务。感谢您对公司的关注。责任编辑：栎树 金融界8月12日消息，有投资者在互动平台向供销大集提问：请问董秘，公司股价一直下跌，刚涨一点 就有大量的卖单持续拋售，是否跟战投获利拋售大集股票有关，如果是这样的话那么战投公司作为大集 投资者有减持股票的行为，为什么公司没有战投减持股票公告，战投这样一直隐性拋售卖出合法合规 吗？ ...

Core Viewpoint - The company *ST Lingda is facing significant financial and operational challenges, including a lack of actual control, ongoing litigation, and a substantial decline in revenue and profit, which raises concerns about its future viability and potential bankruptcy [1][5][6]. Financial Performance - In 2024, *ST Lingda reported a revenue of 61.15 million yuan, a year-on-year decrease of 92.71% [3]. - The net profit attributable to shareholders was -950 million yuan, representing a 262.42% year-on-year decline [3]. Corporate Governance and Control - The company has no actual controlling shareholder following the judicial transfer of shares from its original major shareholder to settle debts [5][6]. - Wang Mingsheng, the legal representative, has significant stakes in related entities but is indirectly linked to *ST Lingda [2][3]. Legal and Operational Issues - The company is under consumption restrictions due to a financing lease dispute with Haier Financing Leasing Co., Ltd., involving an amount of approximately 11.69 million yuan [2]. - *ST Lingda is involved in multiple lawsuits and has been subject to regulatory scrutiny for information disclosure violations [1][2]. Restructuring Efforts - The pre-restructuring process for *ST Lingda has been ongoing for over a year, with no clear resolution in sight [1][5]. - The company is coordinating financial arrangements to address its obligations and mitigate impacts on its reputation and financing capabilities [2]. Subsidiary Challenges - The subsidiary Jinzhai Jiayue has faced operational difficulties, including cash flow issues and halted production of PERC-type solar cells [4]. - Jinzhai Jiayue has also been involved in legal disputes and has announced the termination of its second-phase TOPCon battery production project [4].

公司股票（股票简称：ST西发，股票代码：000752）于2025年8月6日、2025年8月7日、2025年8月8日 连续3个交易日收盘价格涨幅偏离值累计达到15.29%，根据《深圳证券交易所股票上市规则》的相关规 定，属于股票交易异常波动的情况。 二、对重要问题的关注、核实情况 针对公司股票异常波动，公司对有关事项进行了核查，就有关情况说明如下： 登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 特别风险提示： 1.公司于2025年7月22日披露了《关于交易处于筹划阶段的提示性公告》，本次交易尚未正式实施，最 终交易能否完成存在不确定性，敬请投资者理性投资，注意投资风险。 2.截至本公告日，公司仍处于预重整阶段，尚未收到法院关于受理重整申请的文书。公司是否能进入重 整程序尚存在不确定性。如果法院裁定受理申请人提出的重整申请，根据《深圳证券交易所股票上市规 则》第9.4.1条的相关规定，深交所将可能对公司股票交易实施退市风险警示。即使法院正式受理重整申 请，后续仍然存在因重整失败而被宣告破产并被实施破产清算的风险。 ...

Group 1 - Beijing Huiyuan issued a public letter on August 9, highlighting issues with its major shareholder, Zhuji Wenshenghui, including failure to fulfill capital contribution obligations and control over company governance, which infringes on the rights of minority shareholders [1][2] - The public letter revealed a significant mismatch between shareholder rights and capital contribution obligations, with Zhuji Wenshenghui committing to invest 1.6 billion but only contributing 22.8% of the registered capital, resulting in an overdue amount of 850 million [3] - The company has initiated legal action against Zhuji Wenshenghui and Wensheng Assets, which has been accepted by the court, due to the latter's failure to meet investment obligations [3][4] Group 2 - National Water Investment, which holds a 21.89% stake in Beijing Huiyuan through Zhuji Wenshenghui, may face uncertainties regarding its investment returns following the lawsuit initiated by Beijing Huiyuan [5][6] - National Water's previous plans to acquire additional shares from Shanghai Yongrui were halted due to a court-ordered freeze on the shares, complicating its investment strategy [6] - In 2024, National Water reported a revenue of 179 million, a decrease of 20.73%, while its net profit increased by 43.58% to 43.58 million, with investment income from Zhuji Wenshenghui accounting for 165.29% of its net profit [7][8]

Core Viewpoint - The company, Zhongji Health Industry Co., Ltd., is undergoing a pre-restructuring process initiated by the court, aiming to recruit restructuring investors to optimize its financial and governance structure while protecting the rights of creditors and stakeholders [1][3][26]. Company Overview - Zhongji Health was established on June 30, 1994, with a registered capital of 771.283579 million yuan and is located in the Xinjiang Uygur Autonomous Region. The company was listed on the Shenzhen Stock Exchange in September 2000, with the stock code 000972 [1]. - The subsidiary, Xinjiang Zhongji Red Tomato Industry Co., Ltd., was founded on December 30, 2008, with a registered capital of 1.4712938 billion yuan, serving as a core asset within the company [2]. Recruitment Purpose - The recruitment aims to attract both industrial and financial investors to leverage their advantages for resource integration, risk mitigation, and optimization of the asset-liability structure, equity structure, and corporate governance, ultimately ensuring sustainable operations and profitability [3]. Investor Requirements - Interested restructuring investors must be legally established entities or individuals with good commercial reputation and no significant legal violations in the past three years. They should also have a clear decision-making process and sufficient financial capability, with a minimum total asset of 30 billion yuan and revenue of at least 3 billion yuan in the last fiscal year [6][7][8]. Recruitment and Selection Process - The registration period for interested investors is until August 22, 2025, with specific documentation required, including a registration intention letter, confidentiality agreement, and proof of financial capability [9][10][18]. - A registration deposit of 30 million yuan is required by the same deadline, which will be returned to unsuccessful applicants within ten working days after the selection results are announced [19][24]. Other Matters - The recruitment process will be conducted in Chinese, and all submitted documents must be in Chinese or accompanied by a Chinese translation [25].

证券代码：000972 证券简称：*ST 中基 公告编号：2025-063 号 本次招募旨在分别引入产业投资人和财务投资人，借助重整投资人的综合优势，有效整合 资源、化解风险，优化资产负债结构、股本结构和公司治理结构，最终打造资产质量优良、股 权结构合理、治理结构完善、具备持续经营能力和盈利能力的公司，依法保护债权人、职工、 广大中小投资者等相关主体的合法权益，依法协调推进和统筹完成中基健康与红色番茄公司的 预重整及重整工作。 三、意向重整投资人须知 性效力。 健康、红色番茄公司与临时管理人不承担任何瑕疵担保责任。 中基健康产业股份有限公司 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导性陈述或者重大遗 漏。 院"）作出（2025）兵 06 破申（预）1 号《预重整通知书》，启动对中基健康产业股份有限 公司（以下简称"中基健康"或"公司"）的预重整。同日，六师中院出具（2025）兵 06 破 申（预）1 号《确定书》，确定中基健康清算组担任中基健康临时管理人（以下简称"临时管 理人"）。2025 年 7 月 28 日，六师中院作出（2025）兵 06 破申（预）2 号《预重整通知书》 ...

*ST聆达（300125）公告，公司预重整相关工作正在积极推进。2025年3月28日，公司与产业投资人、 财务投资人签署了《重整投资协议》。根据协议，重整投资人将为公司注入资金，帮助公司优化资产负 债结构，提升持续经营能力。目前，公司尚未收到法院关于进入重整程序的相关法律文书，重整程序存 在不确定性。公司股票可能被实施退市风险警示，甚至面临被终止上市的风险。公司将密切关注相关进 展情况，并及时履行信息披露义务。 ...

股票简称：步步高 股票代码：002251 公告编号：2025-034 本公司及董事会全体成员保证公告内容的真实、准确和完整，不存在虚假记载、误导性陈述 或重大遗漏。 特别提示： 一、 本次解除限售股份取得的基本情况 | 序号 股东名称 | | | | | | | 取得股份数（股） | | | | 持股比例 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 上海宏翼私募基金管理有限公司－宏翼一号私募证 | | | | | | | | | | | | | | | | 券投资基金 | | | | | | | | | | | | | | | | 2 上海宏翼私募基金管理有限公司－宏翼红林 | | | | | | | 号私募 | | | | | | | | | 证券投资基金 | | | | | | | | | | | | | | | | 青岛鹿秀投资管理有限公司－鹿秀驯鹿 31 | | | | | | | 号私募证 | | | | | | | | | 券投资基金 | ...

证券时报记者刘灿邦实习生云靖童 *ST金刚主营业务为光伏异质结(HJT)电池片等业务，公司当前正处于预重整阶段，2024年，公司实现 营业收入1.24亿元，同比下降78.69%，净利润亏损扩大至7.95亿元，净资产为-7.95亿元，已处于资不抵 债状态；截至2025年一季度末，公司资产负债率升至134.08%。 谈及上述协议签署后对公司的影响，*ST金刚表示，信达投资长期看好公司及未来业务发展，基于对公 司本次重整的支持，积极投放共益债。 公告显示，未来，该笔共益债资金在信达投资另行审批通过及双方协商一致情形下，可以转化为重整投 资款或者纾困借款，进一步体现了信达投资对*ST金刚未来发展的长期支持。后者也将就落实纾困借 款、算力业务融资等积极与信达投资开展磋商，助力公司业务长期、稳定发展。 *ST金刚认为，本次新增共益债资金将用于预重整期间及重整期间公司及下属核心子公司的日常经营， 有利于提升现有产能以保障优质境外异质结电池片订单的交付，有利于公司整体提升异质结产品竞争力 及品牌影响力，有利于更好实现公司资产保值增值、提升公司的重整价值，有利于维护全体债权人、中 小股东的利益。 值得一提的是，*ST金刚还就公 ...

深圳市名家汇科技股份有限公司 一、预重整事项概况 2024年5月17日，深圳市名家汇科技股份有限公司（以下简称"公司""名家汇"）收到债权人中山市古月 灯饰制造有限公司（以下简称"申请人"）发来的《告知函》，申请人以公司不能清偿到期债务且明显缺 乏清偿能力，但具有重整价值为由，于同日向深圳市中级人民法院（以下简称"深圳中院"）申请对公司 进行重整，并同时申请启动预重整程序。 2024年5月24日，公司于全国企业破产重整案件信息网查询得知，深圳中院已就公司相关事项设立案号 〔2024〕粤03破申481号。2024年5月27日，公司收到深圳中院下发的相关通知书。 2024年7月30日，公司收到深圳中院下发的〔2024〕粤03破申481号《决定书》，法院于7月29日决定对 公司启动预重整程序。经摇珠选定，深圳中院指定深圳市正源清算事务有限公司为公司预重整管理人。 关于被债权人申请重整及预重整的进展暨风险提示公告 登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 证券代码：300506 证券简称：ST名家汇 公告编号：2 ...